Expression and detrimental role of hematopoietic prostaglandin D synthase in spinal cord contusion injury

GLIA

Volumn 59, Issue 4, 2011, Pages 603-614

  Redensek, Adriana ^a   Rathore, Khizr I ^a   Berard, Jennifer L ^a   López Vales, Rubèn ^a   Swayne, Leigh Anne ^b   Bennett, Steffany A L ^b   Mohri, Ikuko ^c   Taniike, Masako ^c   Urade, Yoshihiro ^c   David, Samuel ^a  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

Inflammation; Prostaglandins; Spinal cord injury

Indexed keywords

4 BENZHYDRYLOXY 1 [3 (1H TETRAZOL 5 YL)PROPYL]PIPERIDINE; ENZYME INHIBITOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; METALLOTHIONEIN II; PROSTAGLANDIN D SYNTHASE; PROSTAGLANDIN D2; PROTEIN; PROTEIN MAC 2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; MACROPHAGE; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD INJURY; UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; FEMALE; GALECTIN 3; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-6; ISOMERASES; MACROPHAGES; MICE; MICE, KNOCKOUT; MICROGLIA; NERVE TISSUE PROTEINS; PIPERIDINES; RECOVERY OF FUNCTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL CORD; SPINAL CORD INJURIES;

EID: 79851487004     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21128     Document Type: Article

References (55)

1. Allan SM, Rothwell NJ. 2001. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2: 734-744.
2. Angeli V, Staumont D, Charbonnier AS, Hammad H, Gosset P, Pichavant M, Lambrecht BN, Capron M, Dombrowicz D, Trottein F. 2004. Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses. J Immunol 172: 3822-3829.
3. Aritake K, Kado Y, Inoue T, Miyano M, Urade Y. 2006. Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase. J Biol Chem 281: 15277-15286.
4. Bartholdi D, Schwab ME. 1997. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: An in situ hybridization study. Eur J Neurosci 9: 1422-1438.
5. Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, Popovich PG. 2006. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 23: 635-659.
6. Bate C, Kempster S, Williams A. 2006. Prostaglandin D2 mediates neuronal damage by amyloid-β or prions which activates microglial cells. Neuropharmacology 50: 229-237.
7. Beuckmann CT, Lazarus M, Gerashchenko D, Mizoguchi A, Nomura S, Mohri I, Uesugi A, Kaneko T, Mizuno N, Hayaishi O, Urade Y. 2000. Cellular localization of lipocalin-type prostaglandin D synthase (β-trace) in the central nervous system of the adult rat. J Comp Neurol 428: 62-78.
8. Bonin F, Ryan SD, Migahed L, Mo F, Lallier J, Franks DJ, Arai H, Bennett SA. 2004. Anti-apoptotic actions of the platelet-activating factor acetylhydrolase I alpha2 catalytic subunit. J Biol Chem 279: 52425-52436.
9. Brambilla R, Bracchi-Ricard V, Hu WH, Frydel B, Bramwell A, Karmally S, Green EJ, Bethea JR. 2005. Inhibition of astroglial nuclear factor κB reduces inflammation and improves functional recovery after spinal cord injury. J Exp Med 202: 145-156.
10. Cafferty WB, Gardiner NJ, Das P, Qiu J, McMahon SB, Thompson SW. 2004. Conditioning injury-induced spinal axon regeneration fails in interleukin-6 knock-out mice. J Neurosci 24: 4432-4443.
11. Cao Z, Gao Y, Bryson JB, Hou J, Chaudhry N, Siddiq M, Martinez J, Spencer T, Carmel J, Hart RB, Filbin MT. 2006. The cytokine interleukin-6 is sufficient but not necessary to mimic the peripheral conditioning lesion effect on axonal growth. J Neurosci 26: 5565-5573.
12. 2 ameliorates experimental autoimmune encephalomyelitis. J Immunol 168: 2508-2515.
13. Donnelly DJ, Popovich PG. 2008. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 209: 378-388.
14. Dumont RJ, Okonkwo DO, Verma S, Hurlbert RJ, Boulos PT, Ellegala DB, Dumont AS. 2001. Acute spinal cord injury, Part 1: Pathophysiologic mechanisms. Clin Neuropharmacol 24: 254-264.
15. Faden AI, Lemke M, Demediuk P. 1988. Effects of BW755C, a mixed cyclo-oxygenase-lipoxygenase inhibitor, following traumatic spinal cord injury in rats. Brain Res 463: 63-68.
16. Ghasemlou N, Kerr BJ, David S. 2005. Tissue displacement and impact force are important contributors to outcome after spinal cord contusion injury. Exp Neurol 196: 9-17.
17. Glaser J, Gonzalez R, Perreau VM, Cotman CW, Keirstead HS. 2004. Neutralization of the chemokine CXCL10 enhances tissue sparing and angiogenesis following spinal cord injury. J Neurosci Res 77: 701-708.
18. Glaser J, Gonzalez R, Sadr E, Keirstead HS. 2006. Neutralization of the chemokine CXCL10 reduces apoptosis and increases axon sprouting after spinal cord injury. J Neurosci Res 84: 724-734.
19. Hains BC, Yucra JA, Hulsebosch CE. 2001. Reduction of pathological and behavioral deficits following spinal cord contusion injury with the selective cyclooxygenase-2 inhibitor NS-398. J Neurotrauma 18: 409-423.
20. Hannila SS, Filbin MT. 2008. The role of cyclic AMP signaling in promoting axonal regeneration after spinal cord injury. Exp Neurol 209: 321-332.
21. Hayaishi O, Urade Y. 2002. Prostaglandin D2 in sleep-wake regulation: Recent progress and perspectives. Neuroscientist 8: 12-15.
22. Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, Ichimasa M, Sugamura K, Nakamura M, Takano S, Nagata K. 2001. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 193: 255-261.
23. Kerr BJ, Girolami EI, Ghasemlou N, Jeong SY, David S. 2008. The protective effects of 15-deoxy-delta-(12, 14)-prostaglandin J2 in spinal cord injury. Glia 56: 436-448.
24. Kostenis E, Ulven T. 2006. Emerging roles of DP, CRTH2 in allergic inflammation. Trends Mol Med 12: 148-158.
25. Kwon BK, Tetzlaff W, Grauer JN, Beiner J, Vaccaro AR. 2004. Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J 4: 451-464.
26. Lefer AM, Tsao P, Aoki N, Palladino MAJr. 1990. Mediation of cardioprotection by transforming growth factor-β. Science 249: 61-64.
27. Lewis RA, Soter NA, Diamond PT, Austen KF, Oates JA, Roberts LJII. 1982. Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol 129: 1627-1631.
28. Liu FT, Hsu DK, Zuberi RI, Kuwabara I, Chi EY, Henderson WRJr. 1995. Expression and function of galectin-3, a β-galactoside-binding lectin, in human monocytes and macrophages. Am J Pathol 147: 1016-1028.
29. Liu M, Eguchi N, Yamasaki Y, Urade Y, Hattori N, Urabe T. 2009. Protective role of hematopoietic prostaglandin D synthase in transient focal cerebral ischemia in mice. Neuroscience 163: 296-307.
30. Lopez-Vales R, Garcia-Alias G, Guzman-Lenis MS, Fores J, Casas C, Navarro X, Verdu E. 2006. Effects of COX-2 and iNOS inhibitors alone or in combination with olfactory ensheathing cell grafts after spinal cord injury. Spine 31: 1100-1106.
31. Matsuoka T, Hirata M, Tanaka H, Takahashi Y, Murata T, Kabashima K, Sugimoto Y, Kobayashi T, Ushikubi F, Aze Y, Eguchi N, Urade Y, Yoshida N, Kimura K, Mizoguchi A, Honda Y, Nagai H, Narumiya S. 2000. Prostaglandin D2 as a mediator of allergic asthma. Science 287: 2013-2017.
32. McTigue DM, Popovich PG, Morgan TE, Stokes BT. 2000. Localization of transforming growth factor-beta1 and receptor mRNA after experimental spinal cord injury. Exp Neurol 163: 220-230.
33. Mohri I, Eguchi N, Suzuki K, Urade Y, Taniike M. 2003. Hematopoietic prostaglandin D synthase is expressed in microglia in the developing postnatal mouse brain. Glia 42: 263-274.
34. Mohri I, Kadoyama K, Kanekiyo T, Sato Y, Kagitani-Shimono K, Saito Y, Suzuki K, Kudo T, Takeda M, Urade Y, Murayama S, Tanike M. 2007. Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease. J Neuropathol Exp Neurol 66: 469-480.
35. Mohri I, Taniike M, Taniguchi H, Kanekiyo T, Aritake K, Inui T, Fukumoto N, Eguchi N, Kushi A, Sasai H, Kanaoka Y, Ozono K, Narumiya S, Suzuki K, Urade Y. 2006. Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher. J Neurosci 26: 4383-4393.
36. O'Banion MK, Kyrkanides S, Olschowka JA. 2002. Selective inhibition of cyclooxygenase-2 attenuates expression of inflammation-related genes in CNS injury. Adv Exp Med Biol 507: 155-160.
37. Okada S, Nakamura M, Mikami Y, Shimazaki T, Mihara M, Ohsugi Y, Iwamoto Y, Yoshizaki K, Kishimoto T, Toyama YOkano H. 2004. Blockade of interleukin-6 receptor suppresses reactive astrogliosis and ameliorates functional recovery in experimental spinal cord injury. JNeurosci Res 76: 265-276.
38. Perrella MA, Yoshizumi M, Fen Z, Tsai JC, Hsieh CM, Kourembanas S, Lee ME. 1994. Transforming growth factor-β 1, but not dexamethasone, down-regulates nitric-oxide synthase mRNA after its induction by interleukin-1 beta in rat smooth muscle cells. J Biol Chem 269: 14595-14600.
39. Pineau I, Lacroix S. 2007. Proinflammatory cytokine synthesis in the injured mouse spinal cord: Multiphasic expression pattern and identification of the cell types involved. J Comp Neurol 500: 267-285.
40. 12-14 PGJ2. Proc Natl Acad Sci USA 104: 20979-20984.
41. Resnick DK, Graham SH, Dixon CE, Marion DW. 1998. Role of cyclooxygenase 2 in acute spinal cord injury. J Neurotrauma 15: 1005-1013.
42. Rotshenker S. 2009. The Role of Galectin-3/MAC-2 in the Activation of the Innate-Immune Function of Phagocytosis in Microglia in Injury and Disease. J Mol Neurosci.
43. Saleem S, Zhuang H, de Brum-Fernandes AJ, Maruyama T, Narumiya S, Dore S. 2007. PGD(2) DP1 receptor protects brain from ischemia-reperfusion injury. Eur J Neurosci 26: 73-78.
44. Spik I, Brenuchon C, Angeli V, Staumont D, Fleury S, Capron M, Trottein F, Dombrowicz D. 2005. Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse. J Immunol 174: 3703-3708.
45. Sroga JM, Jones TB, Kigerl KA, McGaughy VM, Popovich PG. 2003. Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J Comp Neurol 462: 223-240.
46. Tanaka K, Hirai H, Takano S, Nakamura M, Nagata K. 2004. Effects of prostaglandin D2 on helper T cell functions. Biochem Biophys Res Commun 316: 1009-1014.
47. Taniguchi H, Mohri I, Okabe-Arahori H, Aritake K, Wada K, Kanekiyo T, Narumiya S, Nakayama M, Ozono K, Urade Y, et al. 2007. Prostaglandin D2 protects neonatal mouse brain from hypoxic ischemic injury. J Neurosci 27: 4303-4312.
48. Ujihara M, Horiguchi Y, Ikai K, Urade Y. 1988. Characterization and distribution of prostaglandin D synthetase in rat skin. J Invest Dermatol 90: 448-451.
49. Urade Y, Fujimoto N, Hayaishi O. 1985a. Purification and characterization of rat brain prostaglandin D synthetase. J Biol Chem 260: 12410-12415.
50. Urade Y, Kaneko T, Fujimoto N, Watanabe Y, Mizuno N, Hayaishi O. 1985b. Purification, characterization, and immunohistochemistry of rat brain prostaglandin D synthetase. Adv Prostaglandin Thromboxane Leukot Res 15: 549-551.
51. Urade Y, Kitahama K, Ohishi H, Kaneko T, Mizuno N, Hayaishi O. 1993. Dominant expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus, and oligodendrocytes of the adult rat brain. Proc Natl Acad Sci USA 90: 9070-9074.
52. Urade Y, Ujihara M, Horiguchi Y, Igarashi M, Nagata A, Ikai K, Hayaishi O. 1990. Mast cells contain spleen-type prostaglandin D synthetase. J Biol Chem 265: 371-375.
53. Urade Y, Ujihara M, Horiguchi Y, Ikai K, Hayaishi O. 1989. The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. J Immunol 143: 2982-2989.
54. West AK, Hidalgo J, Eddins D, Levin ED, Aschner M. 2008. Metallothionein in the central nervous system: Roles in protection, regeneration and cognition. Neurotoxicology 29: 489-503.
55. Yang L, Blumbergs PC, Jones NR, Manavis J, Sarvestani GT, Ghabriel MN. 2004. Early expression and cellular localization of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in human traumatic spinal cord injury. Spine 29: 966-971.